Alena V. Savenka
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: United States Food and Drug Administration (2024–2025); Central Arkansas Veterans Healthcare System (2011–2021); University of Applied Management Studies (2020)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Alena V. Savenka's research program focuses on understanding the mechanisms of cellular injury and the development of potential therapeutic interventions. Her work has investigated the effects of various compounds, including gamma-tocotrienol, on radiation-induced intestinal injury in nonhuman primate models. Savenka has also explored the antimicrobial properties of novel chemical derivatives against Gram-positive bacteria and examined the potential of repurposed vaccines for cancer immunotherapy. Her publications include studies on DNA fragmentation and apoptosis as indicators of kidney injury, as well as proteomic insights into bacterial biofilm formation. Savenka has an h-index of 13 with 37 total publications and 633 citations, and has collaborated with researchers from the University of Arkansas for Medical Sciences and within the National Center for Toxicological Research.
Metrics
- h-index: 13
- Publications: 37
- Citations: 643
Selected Publications
-
Dual Characteristics of Apoptosis and Survival in Cerebellar Purkinje Cells Four Days After Transient Global Ischemia (2026)
-
Antibacterial efficacy and adaptive proteomic strategies of antibiotic-resistant pathogens on nanostructured copper surfaces (2026)
-
Protein expression and morphological adaptations of Campylobacter jejuni under prolonged cold stress in chicken juice (2025)
-
Quantitative proteomic and phenotypic responses of urinary pathogens to CuO/Cu₂O nanoparticles (2025)
-
Examining the viability of five Salmonella enterica subsp. enterica in thymol at 4°C and 25°C using flow cytometry (2025)
-
Species-Specific Stress Responses to Selenium Nanoparticles in Pseudomonas aeruginosa and Proteus mirabilis (2025)
-
Proteomic insights into dual-species biofilm formation of E. coli and E. faecalis on urinary catheters (2025)
-
A flow cytometric assay to detect viability and persistence of Salmonella enterica subsp. enterica serotypes in nuclease-free water at 4 and 25°C (2024)
-
Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy (2022)
-
Effects of Gamma-Tocotrienol on Partial-Body Irradiation-Induced Intestinal Injury in a Nonhuman Primate Model (2022)
-
Effects of Gamma-Tocotrienol on Intestinal Injury in a GI-Specific Acute Radiation Syndrome Model in Nonhuman Primate (2022)
-
Antimelanoma activities of chimeric thiazole–androstenone derivatives (2021)
-
POS-066 MITIGATION OF ACUTE NEPHROTOXICITY IN MICE BY INHIBITION OF APOPTOTIC ENDONUCLEASE NETWORK (2021)
-
4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents (2021)
-
TUNEL Assay: A Powerful Tool for Kidney Injury Evaluation (2021)
Collaboration Network
Top Collaborators
- TUNEL Assay: A Powerful Tool for Kidney Injury Evaluation
- Effects of Gamma-Tocotrienol on Intestinal Injury in a GI-Specific Acute Radiation Syndrome Model in Nonhuman Primate
- 4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents
- Effects of Gamma-Tocotrienol on Partial-Body Irradiation-Induced Intestinal Injury in a Nonhuman Primate Model
- Antimelanoma activities of chimeric thiazole–androstenone derivatives
Showing 5 of 7 shared publications
- A flow cytometric assay to detect viability and persistence of Salmonella enterica subsp. enterica serotypes in nuclease-free water at 4 and 25°C
- Proteomic insights into dual-species biofilm formation of E. coli and E. faecalis on urinary catheters
- Species-Specific Stress Responses to Selenium Nanoparticles in Pseudomonas aeruginosa and Proteus mirabilis
- Examining the viability of five Salmonella enterica subsp. enterica in thymol at 4°C and 25°C using flow cytometry
- Quantitative proteomic and phenotypic responses of urinary pathogens to CuO/Cu₂O nanoparticles
- Proteomic insights into dual-species biofilm formation of E. coli and E. faecalis on urinary catheters
- Species-Specific Stress Responses to Selenium Nanoparticles in Pseudomonas aeruginosa and Proteus mirabilis
- Quantitative proteomic and phenotypic responses of urinary pathogens to CuO/Cu₂O nanoparticles
- Protein expression and morphological adaptations of Campylobacter jejuni under prolonged cold stress in chicken juice
- Proteomic insights into dual-species biofilm formation of E. coli and E. faecalis on urinary catheters
- Species-Specific Stress Responses to Selenium Nanoparticles in Pseudomonas aeruginosa and Proteus mirabilis
- Quantitative proteomic and phenotypic responses of urinary pathogens to CuO/Cu₂O nanoparticles
- Proteomic insights into dual-species biofilm formation of E. coli and E. faecalis on urinary catheters
- Species-Specific Stress Responses to Selenium Nanoparticles in Pseudomonas aeruginosa and Proteus mirabilis
- Quantitative proteomic and phenotypic responses of urinary pathogens to CuO/Cu₂O nanoparticles
- Proteomic insights into dual-species biofilm formation of E. coli and E. faecalis on urinary catheters
- Species-Specific Stress Responses to Selenium Nanoparticles in Pseudomonas aeruginosa and Proteus mirabilis
- Quantitative proteomic and phenotypic responses of urinary pathogens to CuO/Cu₂O nanoparticles
- Species-Specific Stress Responses to Selenium Nanoparticles in Pseudomonas aeruginosa and Proteus mirabilis
- Quantitative proteomic and phenotypic responses of urinary pathogens to CuO/Cu₂O nanoparticles
- Antibacterial efficacy and adaptive proteomic strategies of antibiotic-resistant pathogens on nanostructured copper surfaces
- 4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents
- Antimelanoma activities of chimeric thiazole–androstenone derivatives
- 4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents
- Antimelanoma activities of chimeric thiazole–androstenone derivatives
- Effects of Gamma-Tocotrienol on Intestinal Injury in a GI-Specific Acute Radiation Syndrome Model in Nonhuman Primate
- Effects of Gamma-Tocotrienol on Partial-Body Irradiation-Induced Intestinal Injury in a Nonhuman Primate Model
- Effects of Gamma-Tocotrienol on Intestinal Injury in a GI-Specific Acute Radiation Syndrome Model in Nonhuman Primate
- Effects of Gamma-Tocotrienol on Partial-Body Irradiation-Induced Intestinal Injury in a Nonhuman Primate Model
- Effects of Gamma-Tocotrienol on Intestinal Injury in a GI-Specific Acute Radiation Syndrome Model in Nonhuman Primate
- Effects of Gamma-Tocotrienol on Partial-Body Irradiation-Induced Intestinal Injury in a Nonhuman Primate Model
- Effects of Gamma-Tocotrienol on Intestinal Injury in a GI-Specific Acute Radiation Syndrome Model in Nonhuman Primate
- Effects of Gamma-Tocotrienol on Partial-Body Irradiation-Induced Intestinal Injury in a Nonhuman Primate Model
- Effects of Gamma-Tocotrienol on Intestinal Injury in a GI-Specific Acute Radiation Syndrome Model in Nonhuman Primate
- Effects of Gamma-Tocotrienol on Partial-Body Irradiation-Induced Intestinal Injury in a Nonhuman Primate Model
- Effects of Gamma-Tocotrienol on Intestinal Injury in a GI-Specific Acute Radiation Syndrome Model in Nonhuman Primate
- Effects of Gamma-Tocotrienol on Partial-Body Irradiation-Induced Intestinal Injury in a Nonhuman Primate Model
Similar Researchers
Based on overlapping research topics